{"transactions":[{"id":4125937,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-12-19T21:07:28.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50460,"source":{"system":"sec-edgar","filing":"0000899243-17-029155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317029155/doc4.xml","form_type":"4"}},{"id":4237592,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-08-10T20:05:36.000Z","date":"2017-08-08","kind":"sale","acquired":false,"shares":17535,"price":15.0157,"value":263300.2995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $15.00 to $15.15, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49651,"source":{"system":"sec-edgar","filing":"0000899243-17-020046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317020046/doc4.xml","form_type":"4"}},{"id":4260712,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-07-07T20:05:27.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":600,"price":15,"value":9000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."}],"balance_after":67186,"source":{"system":"sec-edgar","filing":"0000899243-17-018067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317018067/doc4.xml","form_type":"4"}},{"id":4292343,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-06-05T20:05:42.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":1732,"price":20.9827,"value":36342.0364,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $20.90 to $21.15, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67786,"source":{"system":"sec-edgar","filing":"0000899243-17-015285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317015285/doc4.xml","form_type":"4"}},{"id":4292342,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-06-05T20:05:42.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":9601,"price":20.201,"value":193949.801,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $19.85 to $20.85, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":69518,"source":{"system":"sec-edgar","filing":"0000899243-17-015285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317015285/doc4.xml","form_type":"4"}},{"id":4334644,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-05-03T20:05:25.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":11333,"price":19.997,"value":226626.001,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $19.25 to $20.40, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":79119,"source":{"system":"sec-edgar","filing":"0000899243-17-011610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317011610/doc4.xml","form_type":"4"}},{"id":4357681,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-04-05T20:06:38.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":11333,"price":20.7346,"value":234985.2218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $20.45 to $21.25, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":90452,"source":{"system":"sec-edgar","filing":"0000899243-17-009488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317009488/doc4.xml","form_type":"4"}},{"id":4402637,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-03-03T21:05:36.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":11333,"price":24.1923,"value":274171.3359,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $23.85 to $24.625, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":101785,"source":{"system":"sec-edgar","filing":"0000899243-17-006341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317006341/doc4.xml","form_type":"4"}},{"id":4467922,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-02-03T21:05:50.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":11333,"price":27.3674,"value":310154.7442,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $26.95 to $27.95, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":113118,"source":{"system":"sec-edgar","filing":"0000899243-17-002713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317002713/doc4.xml","form_type":"4"}},{"id":4497735,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-01-05T21:07:02.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":683,"price":28.6037,"value":19536.3271,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $28.525 to $28.70, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":124451,"source":{"system":"sec-edgar","filing":"0000899243-17-000442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317000442/doc4.xml","form_type":"4"}},{"id":4497734,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-01-05T21:07:02.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":10650,"price":27.9048,"value":297186.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.50 to $28.50, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":125134,"source":{"system":"sec-edgar","filing":"0000899243-17-000442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924317000442/doc4.xml","form_type":"4"}},{"id":4532749,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-06T00:00:30.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":8133,"price":27.5517,"value":224077.9761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $27.45 to $27.80 inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.s"}],"balance_after":135784,"source":{"system":"sec-edgar","filing":"0001140361-16-088854","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000114036116088854/doc1.xml","form_type":"4"}},{"id":4532748,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-06T00:00:30.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":3200,"price":27.0141,"value":86445.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $26.40 to $27.35 inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.s"}],"balance_after":143917,"source":{"system":"sec-edgar","filing":"0001140361-16-088854","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000114036116088854/doc1.xml","form_type":"4"}},{"id":4567349,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-03T20:05:40.000Z","date":"2016-11-01","kind":"sale","acquired":false,"shares":11333,"price":27.5339,"value":312041.6887,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.00 to $27.95, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":147117,"source":{"system":"sec-edgar","filing":"0000899243-16-032715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924316032715/doc4.xml","form_type":"4"}},{"id":4583929,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-10-05T20:05:20.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":3237,"price":26.2582,"value":84997.7934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $26.02 to $26.83, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":158450,"source":{"system":"sec-edgar","filing":"0000899243-16-031223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924316031223/doc4.xml","form_type":"4"}},{"id":4583928,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-10-05T20:05:20.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":8096,"price":25.4698,"value":206203.5008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $25.02 to $26.01, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":161687,"source":{"system":"sec-edgar","filing":"0000899243-16-031223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924316031223/doc4.xml","form_type":"4"}},{"id":4610617,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":171047,"kind":"person","name":"Herman Alan C.","position":1,"cik":"0001622080","reported_name":"Herman Alan C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-09-06T20:05:49.000Z","date":"2016-09-01","kind":"sale","acquired":false,"shares":16999,"price":29.985,"value":509715.015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.5450 to $30.24, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":169783,"source":{"system":"sec-edgar","filing":"0000899243-16-028532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924316028532/doc4.xml","form_type":"4"}}]}